Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +61.61%
#3 DogBull DogBull +36.85%
#4 BOOK OF MEME BOOK OF MEME +33.31%
#5 Ontology Gas Ontology Gas +32.12%
#6 Neiro Neiro +22.27%
#7 Nockchain Nockchain +19.56%
#8 Pump.fun Pump.fun +18.85%
#9 Unit Pump Unit Pump +18.85%
#10 rsERG rsERG +18.40%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
株式のランク #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
株価
$0.12164306
最終同期: 2024-11-11
時価総額
$38.53M
変化（1日）
-4.14%
変化（1年）
0.00%
国
AU
取引 PharmAust Limited (PAA)

カテゴリー

Healthcare
PharmAust Limited（PAA）の営業利益率
August 2026 時点の営業利益率 TTM: 0.00%
PharmAust Limited の最新の財務報告と株価によると、現在の営業利益率（TTM）は 0.00% です。2024 年末時点では 0.00% でした。
PharmAust Limited の営業利益率の履歴（2001 から 2026）
各年末の営業利益率
年 営業利益率 変化
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% -100.00%
2023 -128.28% 57.79%
2022 -81.30% -37.62%
2021 -130.34% 91.87%
2020 -67.93% 94.09%
2019 -35.00% -54.92%
2018 -77.64% 96.01%
2017 -39.61% -41.89%
2016 -68.16% -17.97%
2015 -83.09% 16.52%
2014 -71.31% 97.92%
2013 -36.03% -86.21%
2012 -261.31% -30.50%
2011 -375.99% 873.56%
2010 -38.62% 8.94%
2009 -35.45% -61.38%
2008 -91.79% 3.86%
2007 -88.38% 62.76%
2006 -54.30% -4.05%
2005 -56.59% -82.53%
2004 -323.98% -88.85%
2003 -2,904.41% 428.71%
2002 -549.34% 0.00%
2001 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。